Abstract
The safety and efficacy of transmyocardial laser revascularization (TMR) is best demonstrated by the data collected from several multi-institutional randomized controlled trials. These trials are an important link between the preclinical data and the most common use of TMR (TMR + Coronary Artery Bypass Grafting). In addition to significant symptomatic relief both short- and long-term objective data were also garnered in these studies. A review of the history, study design, and outcomes is provided.
Original language | English (US) |
---|---|
Pages (from-to) | 46-51 |
Number of pages | 6 |
Journal | Seminars in thoracic and cardiovascular surgery |
Volume | 18 |
Issue number | 1 |
DOIs | |
State | Published - 2006 |
Keywords
- TMR
- clinical trials
- sole therapy
ASJC Scopus subject areas
- Surgery
- Pulmonary and Respiratory Medicine
- Cardiology and Cardiovascular Medicine